Related Experiment Video

Updated: Jul 24, 2026

Exploring the Two Herb Combination Strategy to Treat Injured PC12 Cells
10:33

Exploring the Two Herb Combination Strategy to Treat Injured PC12 Cells

Published on: November 18, 2022

Systemic sclerosis: hypothesis-driven treatment strategies

Christina Charles1, Philip Clements, Daniel E Furst

  • 1Department of Medicine, Division of Rheumatology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095-1670, USA.

Lancet (London, England)
|May 23, 2006
PubMed

Insights

Treatments targeting vascular complications in systemic sclerosis show success, improving quality of life and survival. While anti-fibrosis strategies are still developing, new approaches offer future promise for this complex autoimmune disease.

Area of Science:

  • Rheumatology
  • Immunology
  • Vascular Medicine

Background:

  • Systemic sclerosis is a complex autoimmune disease characterized by vascular damage, fibrosis, and immune system abnormalities.
  • Understanding the pathogenesis of systemic sclerosis is crucial for developing effective therapeutic strategies.

Purpose of the Study:

  • To review controlled and randomized controlled trials examining the pathogenesis of systemic sclerosis.
  • To evaluate the efficacy of current and emerging treatments for systemic sclerosis.

Main Methods:

  • Systematic review of data from controlled trials and randomized controlled trials.
  • Analysis of treatment strategies for vascular complications, fibrosis, and systemic features.

Main Results:

  • Therapies targeting vascular complications, such as renal crisis and pulmonary arterial hypertension, have demonstrated significant success.
  • Immunosuppressive therapy, particularly cyclophosphamide, shows efficacy, with autologous stem-cell transplantation trials ongoing.
  • Direct anti-fibrosis strategies (e.g., bosentan, interferon gamma, relaxin) have yielded disappointing results thus far.

Conclusions:

  • Vascular-targeted therapies are disease-modifying compounds for systemic sclerosis, improving patient function, quality of life, and survival.
  • New anti-fibrosis strategies based on molecular understanding hold promise for future systemic sclerosis treatments.
  • Simultaneous treatment of multiple disease features is a consideration for future clinical trials.

More Related Videos

The Efficacy and Underlying Pathway Mechanisms of ShiDuGao Treatment for Anus Eczema Based on GEO Datasets and Network Pharmacology12:34

The Efficacy and Underlying Pathway Mechanisms of ShiDuGao Treatment for Anus Eczema Based on GEO Datasets and Network Pharmacology

Published on: January 12, 2024

Related Concept Videos

Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Treatment Strategies for Psychological Disorders01:24

Treatment Strategies for Psychological Disorders

Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...